Earlier studies in T2DM patients have shown that ε2 and ε4 alleles of APOE are associated with high risk for dyslipidemia, nephropathy, retinopathy, and coronary artery disease [18,49-51] but other studies have shown contradictory results. This evidence concerns the gene APOE and kidney disorder.